Synthesis, in Vivo and in Silico Studies of N-Aryl-4-(1,3-Dioxoisoindolin-2-Yl)Benzamides as an Anticonvulsant Agent

Parisa Kiminejad Malaie ¹, Mehdi Asadi ², Faezeh Sadat Hosseini ² , Mahmood Biglar ³, Massoud Amanlou ^2,3,4 *

Cited by CrossRef: 4

1- Tabatabaei Rafiei L, Asadi M, Hosseini F, Amanlou A, Biglar M, Amanlou M. Synthesis and Evaluation of Anti-Epileptic Properties of New Phthalimide-4,5-Dihydrothiazole-Amide Derivatives. Polycyclic Aromatic Compounds. 2022;42(4):1271 [Crossref]

2- Asadollahi A, Asadi M, Hosseini F, Ekhtiari Z, Biglar M, Amanlou M. Synthesis, molecular docking, and antiepileptic activity of novel phthalimide derivatives bearing amino acid conjugated anilines. Res Pharma Sci. 2019;14(6):534 [Crossref]

3- Amanlou A, Nassireslami E, Hosseini F, Dehpour A, Rashidian A, Chamanara M. Synthesis, Docking and Antiepileptic Activity of New 2-((1,5-Diphenyl-1H-1,2,4-Triazol-3-yl)Thio)-N-Phenylacetamide Derivatives. Polycyclic Aromatic Compounds. 2022;42(9):6429 [Crossref]

4- khademi M, Moradkhani F, Hosseini F, Asadi M, Amanlou A, Khorasani R, Morgani A, Amanlou M. Synthesis, molecular docking, and antiepileptic activity of new N-phthaloylglycine derivatives. J IRAN CHEM SOC. 2022;19(6):2467 [Crossref]

Submit Your Paper Editorial Board Instructions for Authors Instructions for Reviewers Contact Us Editorial Policies Peer Review Archive

Indexing & Abstracting:

Follow us on LinkedIn
Follow us on Twitter

Director-in-Charge:
Prof. Khosro Adibkia

Editor-in-Chief:
Prof. Ali Shayanfar

Follower of ICMJE